BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15353353)

  • 21. Prolyl isomerase Pin1 regulates the osteogenic activity of Osterix.
    Lee SH; Jeong HM; Han Y; Cheong H; Kang BY; Lee KY
    Mol Cell Endocrinol; 2015 Jan; 400():32-40. PubMed ID: 25463757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Landscape of Pin1 in the cell cycle.
    Lin CH; Li HY; Lee YC; Calkins MJ; Lee KH; Yang CN; Lu PJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):403-8. PubMed ID: 25662955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pin1 and PKMzeta sequentially control dendritic protein synthesis.
    Westmark PR; Westmark CJ; Wang S; Levenson J; O'Riordan KJ; Burger C; Malter JS
    Sci Signal; 2010 Mar; 3(112):ra18. PubMed ID: 20215645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
    Wildemann D; Hernandez Alvarez B; Stoller G; Zhou XZ; Lu KP; Erdmann F; Ferrari D; Fischer G
    Biol Chem; 2007 Oct; 388(10):1103-11. PubMed ID: 17937625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pin1 plays a critical role as a molecular switch in canonical BMP signaling.
    Yoon WJ; Islam R; Cho YD; Ryu KM; Shin HR; Woo KM; Baek JH; Ryoo HM
    J Cell Physiol; 2015 Mar; 230(3):640-7. PubMed ID: 25187260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionally important residues in the peptidyl-prolyl isomerase Pin1 revealed by unigenic evolution.
    Behrsin CD; Bailey ML; Bateman KS; Hamilton KS; Wahl LM; Brandl CJ; Shilton BH; Litchfield DW
    J Mol Biol; 2007 Jan; 365(4):1143-62. PubMed ID: 17113106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
    Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
    Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIN1, the cell cycle and cancer.
    Yeh ES; Means AR
    Nat Rev Cancer; 2007 May; 7(5):381-8. PubMed ID: 17410202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drosophila peptidyl-prolyl isomerase Pin1 modulates circadian rhythms via regulating levels of PERIOD.
    Kang SW; Lee E; Cho E; Seo JH; Ko HW; Kim EY
    Biochem Biophys Res Commun; 2015 Jul; 463(3):235-40. PubMed ID: 25998391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pin1 is required for ultraviolet A-stimulated cyclooxygenase-2 induction in mouse epidermal cells.
    Quyen BT; Choi HK; Kang KW
    Cancer Lett; 2013 Jul; 335(1):31-40. PubMed ID: 23380442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
    Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
    Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.
    Barberi TJ; Dunkle A; He YW; Racioppi L; Means AR
    PLoS One; 2012; 7(1):e29808. PubMed ID: 22238658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosomatid pin1-type peptidyl-prolyl isomerase is cytosolic and not essential for cell proliferation.
    Erben ED; Nardelli SC; de Jesus TC; Schenkman S; Tellez-IƱon MT
    J Eukaryot Microbiol; 2013; 60(1):101-5. PubMed ID: 23206323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pin1 flips Alzheimer's switch.
    Etzkorn FA
    ACS Chem Biol; 2006 May; 1(4):214-6. PubMed ID: 17163675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
    Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
    Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.